[18
January 2022] G.S.R.
20(E).- Whereas a draft of certain rules further to amend the Drugs Rules,
1945, was published as required under sub-section(1) of section 12 and
sub-section(1) of section 33 of the Drugs and Cosmetics Act, 1940 (23 of 1940)
vide notification of the Government of India in the Ministry of Health and
Family Welfare (Department of Health and Family Welfare) number G.S.R. 567(E),
dated the 8th August, 2019, in the Gazette of India, Extraordinary, Part II,
section 3, sub-section (i), inviting objections and suggestions from persons
likely to be affected thereby before the expiry of a period of thirty days from
the date on which the copies of the Official Gazette containing the said
notification were made available to the public; And
whereas, copies of the said Official Gazette were made available to the public
on the 10th August, 2019; And
whereas, objections and suggestions received from the public on the said rules
have been considered by the Central Government; Now,
therefore, in exercise of the powers conferred under sections 12 and 33 of the
Drugs and Cosmetics Act, 1940 (23 of 1940), the Central Government, after
consultation with the Drugs Technical Advisory Board, hereby makes the
following rules further to amend the Drugs Rules, 1945, namely:- (1) These rules may be
called the Drugs (Amendment) Rules, 2022. (2) They shall come into
force on the first day of January, 2023. In the Drugs Rules, 1945, in rule 96, after
sub-rule (4), following sub-rule shall be inserted, namely:- "(5) Every active pharmaceutical
ingredient (bulk drug) manufactured or imported in India shall bear Quick
Response code on its label at each level packaging that store data or
information readable with software application to facilitate tracking and
tracing. The stored data or information shall include the following minimum
particulars, namely:- (i) Unique product
identification code, (ii) Name of the API, (iii) Brand name (if any), (iv) Name and address of
the manufacturer, (v) Batch no., (vi) Batch size, (vii) Date of
manufacturing, (viii) Date of expiry or
retesting, (ix) Serial shipping
container code, (x) Manufacturing licence
no. or import licence no. (xi) Special storage
conditions required (if any).". Drugs
(Amendment) Rules, 2022